Sign In
Buy NPCE
$12.89
-0.86 (-6.25%)
At Close: Jul 31, 2026
NeuroPace: Plenty Of Space To Grow
05:40am, Sunday, 25'th Apr 2021
NeuroPace aims to improve the lives of epilepsy patients. The company has a savvy remote monitoring system which provides real-time action.
NeuroPace, Inc. Announces Pricing of Initial Public Offering
08:45pm, Wednesday, 21'st Apr 2021
MOUNTAIN VIEW, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on developing products to treat and transform the lives of p
Let's Take a Look At Some Upcoming IPOs This Week
10:39am, Monday, 19'th Apr 2021
There have been quite a few appealing Initial Public Offerings (IPOs) available on the market so far this year. Here are some upcoming IPOs that investors should be watching out for.
